We are live on ! Find out more
CA

Cullinan Associates Portfolio holdings

AUM $1.32B
1-Year Est. Return 30.92%
This Fund
S&P 500
This Quarter Est. Return
+3.79%
1 Year Est. Return
+30.92%
3 Year Est. Return
+106.56%
5 Year Est. Return
+134.28%
10 Year Est. Return
+431.49%
AUM
$1.4B
AUM Growth
+$27M
Cap. Flow
-$17.9M
Cap. Flow %
-1.27%
Top 10 Hldgs %
44.95%
Holding
186
New
3
Increased
65
Reduced
63
Closed
6

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$3.62M
2
ABT icon
Abbott
ABT
+$1.86M
3
MSFT icon
Microsoft
MSFT
+$1.63M
4
UNP icon
Union Pacific
UNP
+$1.52M
5
AEP icon
American Electric Power
AEP
+$1.34M

Top Sells

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$16.8M
2
DHR icon
Danaher
DHR
+$6.08M
3
AMT icon
American Tower
AMT
+$4.6M
4
NEE icon
NextEra Energy
NEE
+$2.68M
5
CME icon
CME Group
CME
+$2.33M

Sector Composition

Rank Sector Weight
1 Consumer Staples 34%
2 Technology 14.07%
3 Financials 12.57%
4 Healthcare 9.82%
5 Consumer Discretionary 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TJX icon
51
TJX Companies
TJX
$179B
$7.25M 0.52%
130,050
+13,172
+11% +$718K
ABT icon
52
Abbott
ABT
$188B
$7.21M 0.51%
86,165
+21,935
+34% +$1.86M
AXP icon
53
American Express
AXP
$224B
$7.13M 0.51%
60,257
-550
-0.9% -$67.4K
AMZN icon
54
Amazon
AMZN
$2.44T
$6.93M 0.49%
79,880
+9,800
+14% +$909K
DE icon
55
Deere & Co
DE
$165B
$6.87M 0.49%
40,700
+2,290
+6% +$366K
TROW icon
56
T. Rowe Price
TROW
$25.5B
$6.85M 0.49%
59,935
-2,150
-3% -$239K
FISV
57
Fiserv Inc
FISV
$29.7B
$6.83M 0.49%
65,935
-2,485
-4% -$254K
PSX icon
58
Phillips 66
PSX
$82.9B
$6.7M 0.48%
65,472
+8,957
+16% +$898K
GIS icon
59
General Mills
GIS
$20.2B
$6.68M 0.48%
121,201
+8,235
+7% +$444K
CVS icon
60
CVS Health
CVS
$135B
$6.64M 0.47%
105,359
+17,047
+19% +$1.01M
COF icon
61
Capital One
COF
$128B
$6.36M 0.45%
69,895
DUK icon
62
Duke Energy
DUK
$101B
$6.23M 0.44%
65,013
+3,805
+6% +$346K
T icon
63
AT&T
T
$164B
$6.23M 0.44%
217,862
-17,094
-7% -$453K
CERN
64
DELISTED
Cerner Corp
CERN
$6.16M 0.44%
90,305
+1,170
+1% +$82.8K
EMR icon
65
Emerson Electric
EMR
$81.6B
$6.09M 0.43%
91,035
+4,802
+6% +$302K
SYK icon
66
Stryker
SYK
$135B
$6.02M 0.43%
27,820
-2,025
-7% -$434K
FTV icon
67
Fortive
FTV
$18.2B
$6.01M 0.43%
138,948
-2,537
-2% -$117K
ACN icon
68
Accenture
ACN
$106B
$5.75M 0.41%
29,917
+775
+3% +$150K
MPC icon
69
Marathon Petroleum
MPC
$90.1B
$5.73M 0.41%
94,311
-2,494
-3% -$131K
SCHW
70
Charles Schwab
SCHW
$182B
$5.64M 0.4%
134,850
-300
-0.2% -$12.1K
STZ icon
71
Constellation Brands
STZ
$22.5B
$5.61M 0.4%
27,063
-347
-1% -$69.7K
BRK.B icon
72
Berkshire Hathaway Class B
BRK.B
$1.1T
$5.49M 0.39%
26,379
-1,205
-4% -$248K
TRV icon
73
Travelers Companies
TRV
$81.1B
$5.04M 0.36%
33,916
+1,200
+4% +$178K
MET icon
74
MetLife
MET
$62.4B
$5M 0.36%
105,977
+6,477
+7% +$309K
ITW icon
75
Illinois Tool Works
ITW
$84.1B
$4.96M 0.35%
31,678
-600
-2% -$91.1K

Similar funds

Cullinan Associates's Q3 2019 Portfolio in Review

As of Q3 2019, Cullinan Associates held 186 positions worth $1.4B, up 2% from $1.38B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Trading was light in Q3 2019: portfolio turnover was 4.8%. Cullinan Associates opened 3 new positions and exited 6, leaving the 186-position portfolio largely intact.

By sector, the portfolio is most concentrated in Consumer Staples at 34% of assets, up from 34% a quarter earlier, followed by Technology and Financials.

  • Cullinan Associates's largest Q3 2019 buy was New York Times: 10,000 shares worth $285K.
  • Cullinan Associates added most to Bristol-Myers Squibb in Q3 2019, an estimated $3.62M increase.
  • Cullinan Associates's biggest Q3 2019 reduction was Walmart Inc, cutting an estimated $16.8M.
  • Cullinan Associates fully exited Danaher in Q3 2019, selling an estimated $6.08M.
  • Cullinan Associates's ten largest holdings make up 45% of its $1.4B portfolio in Q3 2019.
  • Cullinan Associates opened 3 new positions and closed 6 in Q3 2019.
  • Cullinan Associates's portfolio value rose 2% quarter-over-quarter to $1.4B.

Based on Cullinan Associates's 13F filing for Q3 2019, filed 1 Oct 2019.